XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 2,384.8 $ (171.8)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:    
Depreciation and amortization 40.5 38.9
Right-of-use asset impairment, net of broker fees 24.8 0.0
Equity-based compensation 122.0 78.3
Non-cash performance allocations and incentive fees (1,662.3) (239.6)
Non-cash principal investment (income) loss (458.3) 646.3
Other non-cash amounts 20.7 (3.5)
Consolidated Funds related:    
Realized/unrealized (gain) loss on investments of Consolidated Funds (100.3) 219.2
Realized/unrealized (gain) loss from loans payable of Consolidated Funds 90.7 (180.3)
Purchases of investments by Consolidated Funds (3,864.4) (2,049.1)
Proceeds from sale and settlements of investments by Consolidated Funds 3,631.7 1,571.4
Non-cash interest income, net (9.0) (4.6)
Change in cash and cash equivalents held at Consolidated Funds 43.5 (258.2)
Change in other receivables held at Consolidated Funds (78.7) (20.0)
Change in other liabilities held at Consolidated Funds 43.4 149.4
Other non-cash amounts of Consolidated Funds 0.0 0.4
Purchases of investments (178.0) (293.7)
Proceeds from the sale of investments 533.8 233.6
Payments of contingent consideration (50.0) 0.0
Changes in deferred taxes, net 449.1 4.7
Change in due from affiliates and other receivables (21.4) (8.3)
Change in deposits and other (23.3) (1.3)
Change in accounts payable, accrued expenses and other liabilities 90.9 (57.5)
Change in accrued compensation and benefits 17.3 73.0
Change in due to affiliates 1.4 (31.5)
Change in lease right-of-use assets and lease liabilities 5.9 (6.7)
Change in deferred revenue 247.6 200.3
Net cash provided by (used in) operating activities 1,302.4 (110.6)
Cash flows from investing activities    
Purchases of fixed assets, net (27.0) (37.3)
Net cash used in investing activities (17.8) (37.3)
Cash flows from financing activities    
Borrowings under credit facilities 70.0 287.1
Repayments under credit facilities 0.0 (300.6)
Issuance of 4.625% subordinated notes due 2061, net of financing costs 484.1 0.0
Payments on debt obligations (231.5) (2.7)
Proceeds from debt obligations, net of financing costs 87.5 20.5
Net borrowings (payments) on loans payable of Consolidated Funds 165.2 594.6
Payments of contingent consideration (0.1) (0.3)
Dividends to common stockholders (266.7) (262.9)
Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8)
Contributions from non-controlling interest holders 57.2 24.2
Distributions to non-controlling interest holders (76.3) (53.5)
Common shares repurchased (84.5) (26.4)
Change in due to/from affiliates financing activities 21.8 40.9
Net cash provided by financing activities 157.9 252.1
Effect of foreign exchange rate changes (26.2) 6.6
Increase in cash, cash equivalents and restricted cash 1,416.3 110.8
Cash, cash equivalents and restricted cash, beginning of period 989.6 828.0
Cash, cash equivalents and restricted cash, end of period 2,405.9 938.8
Supplemental non-cash disclosures    
Tax effects from the conversion to a Corporation recorded in equity 0.0 53.9
Net asset impact of deconsolidation of Consolidated Funds (34.4) 0.0
Reconciliation of cash, cash equivalents and restricted cash, end of period:    
Cash and cash equivalents 2,399.0 938.4
Restricted cash 6.9 0.4
Total cash, cash equivalents and restricted cash, end of period 2,405.9 938.8
Cash and cash equivalents held at Consolidated Funds 134.8 377.8
MRE    
Cash flows from investing activities    
Proceeds from sale, net of cash sold 5.9 0.0
Brazil management entity    
Cash flows from investing activities    
Proceeds from sale, net of cash sold $ 3.3 $ 0.0